MODD · Modular Medical, Inc.
$3.68
+0.26 (+7.60%)
At close · Sep 4
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Even with these proceeds, we do not believe that our cash and cash equivalents will be sufficient to fund our operations for the period of 12 months from the date of issuance of this report, and we would need to raise additional capital. As a result of our expected operating losses and cash burn for the foreseeable future and recurring losses from operations, if we are unable to raise sufficient capital through additional debt or equity arrangements, there will be uncertainty regarding our ability to maintain liquidity sufficient to operate our business effectively, which raises substantial doubt as to our ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$30.00M
Shares
8.15M
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Revenue
$0
FY2018
Net Income
-$28.24M
-50%
FY2026
Diluted EPS
-$12.36
+19%
FY2026
Operating Cash Flow
-$23.75M
-51.1%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $0 | — | — | — | — | — | — | — | — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| $61 | — | — | — | — | $368.92K | $130 | $28.75K | $39.39K | $8518 | $962 | — | — | — | — | — | |
| — | — | — | — | — | — | — | — | — | — | — | $0 | $0 | $0 | $0 | $0 | |
| — | — | — | — | — | — | — | — | — | — | — | $0 | $0 | $0 | $0 | $0 | |
| $19.21M | $19.97M | $14.7M | $12.88M | $9.06M | $7.73M | $4.08M | $3.03M | $1.88M | $332.64K | $0 | — | — | — | — | — | |
| $8.08M | $7.59M | $4.35M | $4.65M | $4.82M | $7.2M | $3.25M | $2.31M | $694.95K | $98.7K | $91.05K | $13.16K | $16.12K | $10.77K | $10.92K | $9513 | |
| $1.76M | $1.67M | $1.06M | $426K | $152K | $117.49K | $111.02K | $35.43K | $14.47K | $1861 | $0 | — | — | $0 | $0 | $0 | |
| $27.29M | $27.56M | $19.05M | $17.53M | $13.88M | $14.93M | $7.34M | $5.35M | $2.58M | $666.16K | $29.42K | — | — | — | — | — | |
| -$27.29M | -$27.56M | -$19.05M | -$17.53M | -$13.88M | -$14.93M | -$7.34M | -$5.35M | -$2.58M | -$666.16K | -$91.05K | -$13.16K | -$16.12K | -$10.77K | -$10.92K | -$9513 | |
| -$25.53M | -$25.89M | -$17.99M | -$17.1M | -$13.73M | -$14.81M | -$7.23M | -$5.31M | -$2.56M | -$664.3K | — | — | — | -$10.77K | -$10.92K | -$9513 | |
| — | — | — | — | — | $2.75M | $39.79K | $0 | — | — | — | — | — | — | — | — | |
| — | — | — | — | — | — | — | — | — | — | — | -$17.92K | -$14.88K | — | -$9870 | -$7979 | |
| — | -$28.24M | -$18.82M | -$17.47M | -$13.88M | -$18.63M | -$7.38M | -$5.32M | -$2.54M | -$657.65K | -$106.56K | -$31.08K | -$30.99K | — | — | — | |
| — | $2000 | $2000 | $2000 | $2000 | $1600 | $1600 | $1600 | $1589 | $1600 | $0 | $0 | $0 | $0 | $0 | $0 | |
| -$28.03M | -$28.24M | -$18.82M | -$17.47M | -$13.88M | -$18.63M | -$7.38M | -$5.32M | -$2.54M | -$659.25K | -$106.56K | -$31.08K | -$30.99K | -$22.79K | -$20.79K | -$17.49K | |
| USD/shares | -$9.85 | -$12.36 | -$15.26 | -$23.40 | -$34.50 | -$82.20 | — | — | — | — | — | — | — | — | — | — |
| USD/shares | -$9.85 | -$12.36 | -$15.26 | -$23.40 | -$34.50 | -$82.20 | — | — | — | — | — | — | — | — | — | — |
| shares | — | 2.29M | 1.23M | 745.9K | 403.43K | 226.92K | 621.16K | 595.49K | 552.99K | 444.54K | 55.05K | 41.66K | 41.66K | 41.66K | 41.66K | 41.66K |
| shares | — | 2.29M | 1.23M | 745.9K | 403.43K | 226.92K | 621.16K | 595.49K | 552.99K | 444.54K | 55.05K | 41.66K | 41.66K | 41.66K | 41.66K | 41.66K |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2017–FY2018: $14.1K in buybacks.
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Debt data is being processed. Please check back later.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 1.24×
EV/EBIT
—
Peer median 19.84×
P/E (TTM)
—
Peer median 21.54×
Peer medians compare against the 70 similar-size Medical Devices companies (of 150 listed).
Key facts
CIK
1074871
CUSIP
60785L306
13F (30d)
19 filings
19 filers
Visit website
Investor relations